Clik here to view.
Indee Labs Issued United States and International Patents for Intracellular...
BERKELEY, Calif. Indee Labs, a biotechnology company developing a scalable, non-viral intracellular delivery system based on microfluidic vortex shedding (µVS), today announced the United States...
View ArticleClik here to view.
Osaka University and Fuzionaire Radioisotope Technologies K.K. to Jointly...
TOKYO & OSAKA, Japan Fuzionaire Radioisotope Technologies K.K. (“FRIT”), a Japanese affiliate of radiopharmaceutical company Fuzionaire Diagnostics, Inc. (“Fuzionaire Dx”), today announced a...
View ArticleClik here to view.
Konkuk University Research Team Identifies Drought-tolerant Process of Plants...
SEOUL, South Korea Konkuk University announced on December 12 that a team of Professor Dae-jin Yun at Konkuk Institute of Technology identified the drought-tolerant process for the first time at the...
View ArticleClik here to view.
21St Century Oncology to Join Australia’s GenesisCare in a Partnership to...
FORT MYERS, Fla. Cancer patients in communities across the U.S. are expected to benefit from increased access to high quality cancer care, with U.S. provider of radiation therapy and integrated...
View ArticleClik here to view.
PCIファーマ・サービシズが英国トレデガー施設の開発・製造能力を拡大するための大規模投資を発表
フィラデルフィア (ビジネスワイヤ) — 世界規模で製薬／バイオ製薬アウトソーシングサービスを提供する一流企業のPCIファーマ・サービシズ（PCI）は本日、臨床供給および商業供給の両面において高薬理活性医薬品の製造・開発能力を強化すべく、英国ウェールズにある当社のトレデガー施設の拡張を開始したと発表しました。...
View ArticleClik here to view.
Genetron Health Announces Strategic Collaboration with CStone
BEIJING Recently, Genetron Health has announced strategic collaboration with CStone Pharmaceuticals (“CStone”), providing companion diagnostic development services and clinical sample testing...
View ArticleClik here to view.
GEDmatch与基因组公司Verogen合作
圣地亚哥，加利福尼亚 (美国商业资讯)–GEDmatch宣布，该公司已经加入法医基因组公司Verogen。GEDmatch作为一家消费级在线谱系分析公司，这项举措能使该公司更好的进行隐私保护，不断提高其网站用户的使用体验。 GEDmatch创始人Curtis...
View ArticleClik here to view.
L&T Technology Services Ltd Develops the World’s First Cost-Effective Robotic...
BANGALORE, India L&T Technology Services Limited (BSE: 540115, NSE: LTTS), India’s leading pure-play engineering services company, was felicitated for its Robotic Endo-training Kit at the 8th...
View ArticleClik here to view.
シアトル・ジェネティクスと武田薬品がアドセトリス（ブレンツキシマブ・ベドチン）の第3相臨床試験のECHELON-1およびECHELON-2の追加解析データ...
米ワシントン州ボセル & マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
XTANDI® (enzalutamide) Approved by U.S. FDA for the Treatment of Metastatic...
NEW YORK & TOKYO Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the U.S. Food and Drug Administration...
View ArticleClik here to view.
Sengenics, a Leading Commercial Stage Precision Medicine Focused Company,...
SINGAPORE Sengenics, a leading commercial stage precision medicine focused company, today announced that Dr Arif Anwar, CEO of Sengenics, has been invited to present at the Biotech Showcase™ during...
View ArticleClik here to view.
RAPID AI Enhanced Advanced Medical Imaging for Stroke Now Installed in Vietnam
MENLO PARK, Calif. RAPID, the worldwide leader in advanced imaging for stroke, is now available and installed in Vietnam. The RAPID artificial intelligence framework helps to quantify brain lesions...
View ArticleClik here to view.
Shandong Fontacea Announces License Agreement with Janssen to Develop and...
JINAN, Shandong, People’s Republic of China Shandong Fontacea Pharmaceutical Co. Ltd. (“Fontacea”) announced today that it has entered into an exclusive license, development and commercialization...
View ArticleClik here to view.
山东方坦思宣布与杨森制药达成许可协议将开发抗IL-17A单克隆抗体并使其商业化
2019年12月17日[美国东部时间 (美国商业资讯)– 山东方坦思生制药有限公司（“方坦思”）今日宣布与强生公司旗下的一家杨森制药公司（“杨森”）签订独家许可、开发和商业化协议，在中华人民共和国（“中国”）包括香港特别行政区（“香港”）、澳门特别行政区（“澳门”）、台湾区域（“台湾”） 和韩国开发含有抗IL-17A单克隆抗体的医药产品并使其商业化。...
View ArticleClik here to view.
Company Profile for Shandong Fontacea Pharmaceutical Co. Ltd.
About Shandong Fontacea Pharmaceutical Co. Ltd. Fontacea is a biopharmaceutical company dedicated to research, development and commercialization of innovative medicines for the global market,...
View ArticleClik here to view.
Terason Partners with AmCad BioMed Corporation to Provide More Efficient...
BURLINGTON, Mass. & TAIPEI, Taiwan Terason, a leading global ultrasound imaging company based in Burlington, Mass., has partnered with AmCad BioMed Corporation to provide its ultrasound imaging...
View ArticleClik here to view.
FDA Grants Accelerated Approval to Astellas’ and Seattle Genetics’ PADCEV™...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the U.S. Food and Drug...
View ArticleClik here to view.
Vantage 2020 Preview: Strong Sales and Product Launches Set the Stage for...
LONDON & BOSTON & TOKYO Oncology dominates the growth outlook for pharma; four of the eight drugs expected to add $1bn or more in new sales next year are for cancer, according to the Vantage...
View ArticleClik here to view.
Turnstone Biologics Announces Global Collaboration and License Agreement with...
NEW YORK Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies, today announced a strategic collaboration with Takeda Pharmaceutical Company...
View ArticleClik here to view.
Promega Corporation Enters License Agreement with MilliporeSigma to Access...
MADISON, Wis. Promega Corporation today announced it has signed a license agreement with MilliporeSigma, a leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome-editing...
View Article